2013
DOI: 10.1016/j.cca.2013.05.021
|View full text |Cite
|
Sign up to set email alerts
|

Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
242
2
3

Year Published

2013
2013
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 286 publications
(257 citation statements)
references
References 38 publications
10
242
2
3
Order By: Relevance
“…miR-106-25 is associated with TGF␤ tumor suppressor signaling pathway in the liver (37), and miR-122 is associated with hepatitis-C (27) and nonalcoholic steatohepatitis (5), which is one of the risk factors for hepatocellular carcinoma (1). Furthermore, plasma levels of miR-122 and miR-34a were higher in patients with nonalcoholic fatty liver disease (55). These findings suggest that exposure to maternal undernutrition in early prenatal life may have an impact on hepatic growth and physiology beyond programming of the insulin-signaling and gluconeogenic pathways.…”
Section: Impact Of Pcun and Piun On Mirsmentioning
confidence: 81%
“…miR-106-25 is associated with TGF␤ tumor suppressor signaling pathway in the liver (37), and miR-122 is associated with hepatitis-C (27) and nonalcoholic steatohepatitis (5), which is one of the risk factors for hepatocellular carcinoma (1). Furthermore, plasma levels of miR-122 and miR-34a were higher in patients with nonalcoholic fatty liver disease (55). These findings suggest that exposure to maternal undernutrition in early prenatal life may have an impact on hepatic growth and physiology beyond programming of the insulin-signaling and gluconeogenic pathways.…”
Section: Impact Of Pcun and Piun On Mirsmentioning
confidence: 81%
“…Although miR-33 antagonism remarkably increases HDL and lowers very lowdensity lipoprotein (VLDL), one recent study reported that long-term inhibition of miR-33 may increase CEs and triglycerides (TGs), leading to hepatic steatosis in mice fed a highfat diet [24] . Hepatic miR-122 is decreased in the livers of NASH patients, while it is increased in the blood [19,25,26] . The silencing of miR-122 caused an accumulation of both cholesterol and TGs in mouse livers [27,28] .…”
Section: Introductionmentioning
confidence: 97%
“…40,44,45 Serum/plasma levels of miR-122 correlate with hepatic necro-inflammation, liver damage, cell death and increased aminotransferase levels in acute and chronic liver diseases. 44,[46][47][48][49] Interestingly, hepatic and circulating miR-122 levels do not correlate in NAFLD 14,39,[50][51][52][53][54][55] or viral hepatitis 41,47,49,56 although both have been statistically associated with various measures of disease severity in these studies. Together these studies show that miR-122 may play a role in most liver diseases.…”
Section: Microrna-122mentioning
confidence: 62%
“…14 Together these studies suggest that differentially expressed miRs in humans and animal models of NASH regulate genes with diverse functions involved in the pathogenesis of NAFLD, including metabolism of lipid and glucose, regulation of the unfolded protein response, endoplasmic reticulum stress, oxidative stress, cellular differentiation, inflammation and apoptosis. 14,36 Notably, miR-34a has been shown to be up-regulated in both human serum 50,51 and liver in humans and animal models of NAFLD. 14,55,121,122 Two recent studies suggest two differing mechanisms for the involvement of miR-34a in NASH pathogenesis through down-regulation of SIRT-1; a) leading to AMP kinase dephosphorylation and subsequent decreased phosphorylation of HMGCoA, ultimately leading to cholesterol accumulation 121 ; b) increased acetylation of p53 causing activation of apoptosis.…”
Section: Non-alcoholic Fatty Liver Disease (Nafld)mentioning
confidence: 99%